Miami Gardens, FLNCT07266831Now EnrollingIRB Ready

Human Immunodeficiency Virus Type 1 (HIV-1) Infection Clinical Trial in Miami Gardens, FL

Access cutting-edge human immunodeficiency virus type 1 (hiv-1) infection treatment through this clinical trial at a research site in Miami Gardens. Study-provided care at no cost to qualified participants.

Sponsored by Merck Sharp & Dohme LLC

Quick Self-Assessment

See if you qualify for this Miami Gardens location

Preparing your pre-screening questions…

Expert Care in Miami Gardens

Access human immunodeficiency virus type 1 (hiv-1) infection specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related human immunodeficiency virus type 1 (hiv-1) infection treatment provided free

Apply for This Miami Gardens Location

Check if you qualify for this human immunodeficiency virus type 1 (hiv-1) infection clinical trial in Miami Gardens, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami Gardens

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami Gardens site if eligible
  4. 4Begin participation

About This Human Immunodeficiency Virus Type 1 (HIV-1) Infection Study in Miami Gardens

Researchers are looking for new ways to treat HIV-1 (Human Immunodeficiency Virus Type 1). The usual (standard) treatment for HIV-1 is antiretroviral therapy (ART), which includes taking medicines to lower the amount of HIV-1 in the body. Standard ART helps people live longer, but people must take up to 3 medicines up to twice a day. Standard ART may also cause other health problems. Researchers want to know if a study ART works as well as a standard ART to treat HIV-1. The study ART combines 2 medicines, islatravir and ulonivirine, and is taken once a week. The goals of this study are to learn: 1) If the study ART works as well as a standard ART to treat HIV-1, and 2) About the safety of the study ART and if people tolerate it compared to a standard ART.

Sponsor: Merck Sharp & Dohme LLC

Who Can Participate

Inclusion Criteria

Phase 2: Is human immunodeficiency virus type 1 (HIV-1) positive with Plasma HIV-1 ribonucleic acid (RNA) ≥500 and ≤100,000 copies/mL.
Phase 3: Is HIV-1 positive with Plasma HIV-1 RNA ≥500 copies/mL.
Phase 2: Has cluster of differentiation 4-positive (CD4+) T-cell count ≥200 cells/mm\^3.
Is naïve to antiretroviral therapy (ART), defined as having received no prior therapy with any antiretroviral agent following a diagnosis of HIV 1 infection.

Exclusion Criteria

Has human immunodeficiency virus type 2 (HIV-2) infection.
Has a diagnosis of an active acquired immune deficiency syndrome (AIDS)-defining opportunistic infection.
Has active hepatitis C virus (HCV) or active hepatitis B virus (HBV) infection.
Has a history of malignancy ≤5 years prior to providing documented informed consent except for adequately treated basal cell or squamous cell skin cancer, in situ cervical or in situ anal cancer, or cutaneous Kaposi's sarcoma.
Has prior exposure to islatravir (ISL) or ulonivirine (ULO) for any duration any time prior to Day 1.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami Gardens?

Yes, this clinical trial (NCT07266831) has an active research site in Miami Gardens, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Human Immunodeficiency Virus Type 1 (HIV-1) Infection Treatment Options in Miami Gardens, FL

If you're searching for human immunodeficiency virus type 1 (hiv-1) infection treatment options in Miami Gardens, FL, this clinical trial (NCT07266831) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami Gardens research site is actively enrolling participants for this clinical trial. You'll receive care from experienced human immunodeficiency virus type 1 (hiv-1) infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all human immunodeficiency virus type 1 (hiv-1) infection clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Miami Gardens, FL

See all multiple myeloma clinical trials recruiting in Miami Gardens — not just this study.

Browse Multiple Myeloma Trials in Miami Gardens

Ready to Join in Miami Gardens?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami Gardens, FL